Annexin A3 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma

Annexin A3 is associated with a poor prognosis in breast cancer and participates in the modulation of apoptosis in vitro by affecting the Bcl-2/Bax balance

(2013) Chao Zeng et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Identifying Resistance Mechanisms against Five Tyrosine Kinase Inhibitors Targeting the ERBB/RAS Pathway in 45 Cancer Cell Lines

(2013) Zsófia Pénzváltó et al.   PLoS One

The role of annexin A3 playing in cancers

(2012) Na Wu et al.   Clinical & Translational Oncology

FBI-1 promotes cell proliferation and enhances resistance to chemotherapy of hepatocellular carcinoma in vitro and in vivo

(2011) Feng Fang et al.   CANCER

Transcriptional Profiling of Peripheral Blood Mononuclear Cells in Pancreatic Cancer Patients Identifies Novel Genes with Potential Diagnostic Utility

(2011) Michael J. Baine et al.   PLoS One

Primary Cell Cultures from Human Renal Cortex and Renal-Cell Carcinoma Evidence a Differential Expression of Two Spliced Isoforms of Annexin A3

(2010) Cristina Bianchi et al.   AMERICAN JOURNAL OF PATHOLOGY

Increased Expression of Annexin A3 Is a Mechanism of Platinum Resistance in Ovarian Cancer

(2010) X. Yan et al.   CANCER RESEARCH

A case-controlled validation study of a blood-based seven-gene biomarker panel for colorectal cancer in Malaysia

(2010) Kok-Thye Yip et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Analysis of ABCG2 expression and side population identifies intrinsic drug efflux in the HCC cell line MHCC-97L and its modulation by Akt signaling

(2008) Chen Hu et al.   CARCINOGENESIS

Expression and Prognostic Relevance of Annexin A3 in Prostate Cancer

(2008) Jens Köllermann et al.   EUROPEAN UROLOGY

The role of annexins in tumour development and progression

(2008) S Mussunoor et al.   JOURNAL OF PATHOLOGY

Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma

(2008) YF Liu et al.   JOURNAL OF PATHOLOGY